NCT02836886View on ClinicalTrials.gov

VircapSeq Virus Detection in Sézary Syndrome

CompletedOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Lymphoma, T-Cell, CutaneousSézary Syndrome
Trial Locations (1)

10032

Columbia University Medical Center, New York

All Listed Sponsors
lead

Columbia University

OTHER

NCT02836886 - VircapSeq Virus Detection in Sézary Syndrome | Biotech Hunter | Biotech Hunter